Humanized immunoglobulin G1 (IgG1) kappa monoclonal antibody (mAb) targeting PAUF
PAUF-I
Phase 2 small_molecule active
Quick answer
Humanized immunoglobulin G1 (IgG1) kappa monoclonal antibody (mAb) targeting PAUF for Advanced and/or metastatic pancreatic adenocarcinoma is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Advanced and/or metastatic pancreatic adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active